פרסומים אקדמיים

"A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12)" accepted 2023 .108566 ScienceDirect- Jornals. Nakhleh A, Goldenberg-Furmanov M, Goldstein R, Shoha M, Shehadeh N.

"Unmet needs in the treatment of childhood TYPE 2 DIABETES: a narrative review" accepted 2023 ADTH-D-23-00323R1 EMID- Advances in Therapy. Greco G, Alborn L, Oneill S.

"Dapagliflozin in children and adolescents (age 10-17 years) with type 2 diabetes" accepted 2023 A-23-977 EASD. Shehadeh N.

"Efficacy and safety of Dapagliflozin (DAPA) or Saxagliptin (SAXA) in youth (Age 10–17 Years) with type 2 diabetes (T2D)" accepted 2023 O-24 ISPAD. Shehadeh N.

"Cardiometabolic Risk Factors Among Children and Adolescents with overweight and Obesity" accepted 2023 ECO congress, Dublin. Nakhleh A., Sakhnini R., Furman E., Shehadeh N.

"Obesity in patients with youth-onset type 2 DM: The Israeli Cohort" accepted 2023 ECO congress, Dublin. Zuckerman Levin N., Shehadeh N.

"Efficacy and Safety of Dapagliflozin or Saxagliptin in Youth (Age 10–17 Years) with Type 2 Diabetes" accepted 2023 ADA. Tamborlane W., Galassetti P., Iqbal N., Karlsson C., Monyak J., Shehadeh N.

"The difference between health policy and action in municipalities – what is really happening?" accepted 2023 Israel Institute for Health Policy Research. Dessau N. and Spitzer S.

"Unmet Needs in the Treatment of Childhood Type 2 Diabetes" accepted 2023 Advances in Diabetes. Tamborlane W., Shehadeh N.

"Efficacy and Safety of Dapagliflozin or Saxagliptin in Youth (Age 10–17 Years) with Type 2 Diabetes" accepted 2023 New England Journal of Medicine. Tamborlane W., Galassetti P., Iqbal N., Karlsson C., Monyak J, Shehadeh N.

"Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study" accepted 2023 Diabetes Research and Clinical Practice. Othman A, Masri A, Zloczower A, Shehadeh N, Nakhleh A,

"Bridging the gap: Understanding pregnant women's preferences and perceived benefits of an mHealth app for GDM self-management" accepted 2023 JMIR. Birati, Y., Yefet E., Yacov Shavit, L., Spitzer S.

Diabetes care guidelines, The National Council of Diabetes, Fasting Ramadan and Yum Kipor, instruction for diabetics " accepted 2023 Ministry of health. Taher R., Shehadeh N.

"Apps don’t work for patients who don’t use them: How will clinicians talk to patients about app adherence?" accepted 2023 Health Affiars. Schwartz D, Spitzer S, Khlemsky M, Cano A, Ray S, Cho T, Sakhnini R, Lanin R, Meir M, Tsai T.

"Implementation Strategies of Social Prescription Platforms: What works?" accepted 2023 Health and Place. Lang T, Spitzer S.

"A Beneficial Role of GLP-1 Receptor Agonist Therapy in ABCC8-MODY" accepted 2023 Diabetes and Its Complications. Nakhleh A, Goldenberg-Furmanov M, Goldstein R, Shohat M, Shehadeh N.

ChatGPT’s Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education. Diabetes Technology and Therapeutics" accepted 2023 PubMed 10.1089/dia.2023.0134. Nakhleh A, Spitzer S, Shehadeh N

"Diabetes care guidelines, The National Council of Diabetes, SPHERE project " accepted 2023 Ministry of health. Shehadeh N, Spitzer S.

"Diabetes care guidelines, The National Council of Diabetes, Hypoglycemia " accepted 2023 Ministry of health. Nakhleh A., Shehadeh N.

"Diabetes care guidelines, The National Council of Diabetes, Diabetes in the Arab population " accepted 2023 Ministry of health. Assalia M., Shehadeh N.

Cultural and Digital Health Literacy Appropriateness of App and Based Systems Designed for Pregnant Women with Gestational Diabetes Mellitus" accepted 2022 Medical Internet Research 24(10):e37844. Birati, Y., Yefet E., Perlitz Y., Shehadeh S., Spitzer S.

Conducting A Community Health Needs Assessment in Culturally Diverse Peripheral Population Groups accepted 2022 International Journal for Equity in Health 21(1):131 . Rayan-Gharra N., Gutler-Ofir M., Spitzer S.https://pubmed.ncbi.nlm.nih.gov/36096852/

Cardiometabolic Risk Factors Among Children and Adolescents with overweight and Class 1 Obesity accepted 2023 Frontiers in Endocrinology. Nakhleh A., Sakhnini R., Furman E., Shehadeh N

פרסומים אקדמיים

תפריט

צור קשר